Correction: Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment

Correction: Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment

Saved in:

Bibliographic Details
Main Authors:	Dae Hoon Lee, Jung Ki Yoo, Ki Hwan Um, Wootae Ha, Soo Min Lee, Junseong Park, Min Jeong Kye, Jungyo Suh, Jin Woo Choi
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	https://doi.org/10.1186/s13046-025-03469-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment
by: Dae Hoon Lee, et al.
Published: (2024-06-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
by: Dong Gyun Kim, et al.
Published: (2023-03-01)

Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis/bladder pain syndrome: A pilot study
by: Ahmed S. El Hefnawy, et al.
Published: (2024-03-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
by: Sayed Ab. Reshad Ghafouri, et al.
Published: (2018-01-01)

INTRACTABLE HEMATURIA IN BLADDER CANCER WITH UNILATERAL HIGH GRADE VESICOURETERAL REFLUX: A CONSERVATIVE APPROACH USING INTRAVESICAL FORMALDEHYDE INSTILLATION
by: Reginald Rustandi, et al.
Published: (2025-05-01)

Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome
by: Stojanović Stevan, et al.
Published: (2023-01-01)

Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
by: Yongheng Zhou, et al.
Published: (2025-04-01)

The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis.
by: Weijian Zhou, et al.
Published: (2022-01-01)

Development and validation of clinical prediction model for post-treatment recurrence in high-risk non-muscle invasive bladder cancer after BCG intravesical instillation
by: WANG Haitao, et al.
Published: (2025-05-01)

Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer
by: Tomonori Kato, et al.
Published: (2015-01-01)

Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
by: Orlane Figaroa, et al.
Published: (2025-06-01)

Dasatinib induces apoptosis and autophagy by suppressing the PI3K/Akt/mTOR pathway in bladder cancer cells
by: Jin-Nyoung Ho, et al.
Published: (2024-11-01)

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01)

Inhibition of mTOR attenuates the initiation and progression of BRCA1‐associated mammary tumors
by: Hye Jung Baek, et al.
Published: (2025-04-01)

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.
by: Lei Li, et al.
Published: (2015-01-01)

The Efficacy and Safety of Hyperthermic Intravesical Chemotherapy Compared with Other Instillation Methods in Treating Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
by: Yingying Yang, et al.
Published: (2024-01-01)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Tanjala T. Gipson, et al.
Published: (2012-01-01)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
by: Uyen To, et al.
Published: (2014-01-01)

Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
by: Geng Yin, et al.
Published: (2017-01-01)

mTOR pathway targeted inhibition via Rapamycin-loaded PLGA nanoparticles for enhanced bladder cancer therapy
by: Nour-Elhoda El-hefnawy, et al.
Published: (2025-07-01)

COTI-2 suppresses the malignancy of bladder cancer by inducing apoptosis via the AMPK-mTOR signaling pathway
by: Yuancai Zheng, et al.
Published: (2025-03-01)

Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?
by: Alvin Lee, et al.
Published: (2016-01-01)

Advancements in bladder cancer immunotherapy: a focus on intravesical approaches
by: Xia Tang, et al.
Published: (2025-07-01)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024-12-01)

The Role of mTOR in Amyotrophic Lateral Sclerosis
by: José Augusto Nogueira-Machado, et al.
Published: (2025-04-01)

Targeting the mTOR pathway in breast cancer
by: Jia Liu, et al.
Published: (2017-06-01)

Orthoflavivirus infection and the mTOR signaling pathway
by: Yahui Zhang, et al.
Published: (2025-04-01)

Transcriptional Co‐Activator With PDZ Binding Motif (TAZ) Inhibits Dexamethasone‐Induced Muscle Atrophy via mTOR Signalling
by: Kyung Min Kim, et al.
Published: (2025-04-01)

The effectiveness of intravesical oxybutynin in the management of overactive bladder: a clinical study
by: Shoeb Alahmad, et al.
Published: (2024-12-01)

mTOR inhibition in management of advanced breast cancer
by: Shona Nag
Published: (2012-01-01)

A comprehensive map of the mTOR signaling network
by: Etienne Caron, et al.
Published: (2010-12-01)

Evaluation of clinical efficacy of pelvic ultrasound monitoring combined with scale scoring in the treatment of interstitial cystitis by intravesical instillation regimen combined with hydrodistention and transurethral fulguration
by: Lin Liu, et al.
Published: (2025-05-01)

As a New Tumor Suppressor Gene, PID1 Activates the AMPK-mTOR Signal to Inhibit the Progression of Bladder Cancer
by: Sun L, et al.
Published: (2025-07-01)

DEPTOR-mTOR Signaling Is Critical for Lipid Metabolism and Inflammation Homeostasis of Lymphocytes in Human PBMC Culture
by: Qi-bing Xie, et al.
Published: (2017-01-01)

IMPAIRED REGULATORY MECHANISMS OF THE mTOR SIGNALING PATHWAY IN OSTEOARTHROSIS
by: Elena Vasilyevna Chetina, et al.
Published: (2012-12-01)

Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors
by: Alexandra Monteiro, et al.
Published: (2025-06-01)

The Role of mTOR in <i>Mycobacterium tuberculosis</i> Infection
by: Ami Patel, et al.
Published: (2024-10-01)

Dysregulated mTOR networks in experimental sporadic Alzheimer’s disease
by: Suzanne M. de la Monte, et al.
Published: (2024-09-01)

<i>Eisenia bicyclis</i> Extract Ameliorates Colitis in In Vitro and In Vivo Models Through Modulation of mTOR Axis and Gut Microbiota Composition
by: Qunzhe Wang, et al.
Published: (2025-02-01)